Palisade Bio (FRA:7NS0) ROE % Adjusted to Book Value : -287.46% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio ROE % Adjusted to Book Value?

Palisade Bio's ROE % for the quarter that ended in Mar. 2024 was -132.23%. Palisade Bio's PB Ratio for the quarter that ended in Mar. 2024 was 0.46. Palisade Bio's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -287.46%.

Palisade Bio ROE % Adjusted to Book Value Historical Data

The historical data trend for Palisade Bio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio ROE % Adjusted to Book Value Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-191.08

-195.81

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial											-65.17	-134.37	-269.53	-177.81	-287.46

Competitive Comparison of Palisade Bio's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Palisade Bio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Palisade Bio's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palisade Bio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Palisade Bio's ROE % Adjusted to Book Value falls into.

Palisade Bio ROE % Adjusted to Book Value Calculation

Palisade Bio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-101.82%	/	0.52
	=	-195.81%

Palisade Bio's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-132.23%	/	0.46
	=	-287.46%

Palisade Bio ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Palisade Bio's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Palisade Bio (FRA:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (FRA:7NS0) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

PALI:USA

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (FRA:7NS0) Headlines

No Headlines